Clinical Trial 22100

• Overview

  Study Title:

  A Dose Escalation and Expansion Study of ABBV-383 in Combination with Anti-Cancer Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma

• Treatments

  Therapies:

  Immunotherapy; Therapy (NOS)

  Medications:

  ABBV-383 (); CC-4047 (Pomalidomide); CC-5013 (Lenalidomide); Daratumumab (Darzalex); Dexamethasone (); Lenalidomide (Revlimid); Nirogacestat (); Pomalidomide ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.